View all cases
UPC APP 68655/2024
- Case details
- StatusWithdrawnActionProcedural applicationCategoryWithdrawal applications
- Parties
- Claimants
- Dexcom Inc.Operating co.
Representatives- Anne-Charlotte le Bihan-Bird & Bird LLP
- Laurent Labatte-Bird & Bird LLP
- David Sproston-Hoffmann Eitle
- Mark Jones-Hoffmann Eitle
Respondents- Abbott LaboratoriesOperating co.
- Abbott Diabetes Care Inc.Operating co.
- Abbott GmbHOperating co.
- Abbott Diagnostics GmbHOperating co.
- Abbott Logistics B.V.Operating co.
- Abbott (S.A./N.V.)Operating co.
- Abbott s.r.l.Operating co.
- Abbott B.V.Operating co.
- Abbott Scandinavia AktiebolagOperating co.
- Abbott FranceOperating co.
Representatives- Christian Dekoninck-Taylor Wessing
- Patricia Cappuyns-Taylor Wessing
- Wim Maas-Taylor Wessing
- Eelco Bergsma-Taylor Wessing
- Thomas Adocker-Taylor Wessing
- Dietrich Kamlah-Taylor Wessing
- Christian Lederer-Taylor Wessing
- Gisbert Hohagen-Taylor Wessing
- François Pochart-August Debouzy
- Division
- Court of Appeal
- Judges
- —
- Language
- —
- First decided
- Jan 24, 2025
How this compares
How long the court takes to reach a first decision.
| Median days to first decision | |
|---|---|
| All UPC | 124 |
At the UPC: Dexcom Group (39 cases)·Abbott Group (67 cases)
Start 14-day free trialAlready a user? Sign in
Related cases
Decisions
- 2025-01-24Application RoP 265Public
Summary: The Court of Appeal allowed DexCom's withdrawal of its infringement action and Abbott's withdrawal of the counterclaims for revocation, declared the proceedings closed, and ordered reimbursement of 60% of DexCom's court fees; as a result the first instance decision revoking DexCom's patent became ineffective.
Show the legal issues (3)
- Withdrawal of infringement action on appeal (R. 265 RoP)
- Effect of withdrawal on prior revocation decision
- Reimbursement of court fees (R. 370.9 RoP)
Documents
- 2B390A64A1F36FDFABE0BA35BDBC58C1_en.pdf2025-01-24EN